MannKind's Tyvaso DPI Royalty Deal Signals Undervaluation [Seeking Alpha]
Liquidia Corporation (LQDA)
Last liquidia corporation earnings: 3/11 07:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
Liquidia's likely entry into the market with a competing formulation poses a slight concern but is unlikely to significantly impact MannKind's market share. MannKind's Q3 earnings showed a strong year-over-year surge, but concerns over equity dilution and a debt-heavy balance sheet remain. MannKind's strategic moves, financial strengthening via the Sagard deal, and a manageable competitive landscape advocate for a "Buy" rating. Evaluating MannKind's Position in Light of Recent Tyvaso DPI Sale MannKind NASDAQ: MNKD ) is down 14% since my "Buy" recommendation in October. This is in spite of favorable advancements. In January, MannKind sold 10% of its Tyvaso DPI, developed in collaboration with United Therapeutics UTHR ), for $150 million upfront (with the potential for an additional $50 million depending on Tyvaso DPI revenue) to Sagard Healthcare. The milestone payment is outlined as follows: $50 million in the event that the trailing 12-month net sales of Tyvaso DPI equals
Show less
Read more
Impact Snapshot
Event Time:
LQDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LQDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LQDA alerts
High impacting Liquidia Corporation news events
Weekly update
A roundup of the hottest topics
LQDA
News
- Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline [Yahoo! Finance]Yahoo! Finance
- When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable? [Yahoo! Finance]Yahoo! Finance
- Liquidia Co. (NASDAQ: LQDA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.MarketBeat
- Liquidia Corporation (NASDAQ:LQDA) has caught the attention of institutional investors who hold a sizeable 38% stake [Yahoo! Finance]Yahoo! Finance
- Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
LQDA
Earnings
- 11/7/23 - Miss
LQDA
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form DEF
- LQDA's page on the SEC website